Skip to main content
. 2015 Sep 2;485:414–421. doi: 10.1016/j.virol.2015.08.005

Fig. 5.

Fig. 5

The proposed model for association between PBoV NP1 and the IRF9 DNA-binding domain. PBoV NP1 interacts with the DNA-binding domain of IRF9 to block the DNA-binding step of ISGF3, resulting in reduction of ISG expression.